Sustained clinical benefit, improved quality of life, and reduced intestinal surgery from maintenance infliximab treatment in inflammatory bowel disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sustained clinical benefit, improved quality of life, and reduced intestinal surgery from maintenance infliximab treatment in inflammatory bowel disease
Authors
Keywords
-
Journal
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 55, Issue 2, Pages 178-183
Publisher
Informa UK Limited
Online
2020-02-13
DOI
10.1080/00365521.2020.1722738
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year
- (2016) Peter R Gibson et al. Clinical and Translational Gastroenterology
- Health Care Resource Use and Costs for Crohn’s Disease before and after Infliximab Therapy
- (2016) Dustin E Loomes et al. CANADIAN JOURNAL OF GASTROENTEROLOGY
- Randomised clinical trial: deep remission in biologic and immunomodulator naïve patients with Crohn's disease - a SONICpost hocanalysis
- (2015) J.-F. Colombel et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
- (2015) Reena Khanna et al. LANCET
- A UK retrospective observational study of clinical outcomes and healthcare resource utilisation of infliximab treatment in Crohn's disease
- (2013) J. O. Lindsay et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study
- (2013) K. Büsch et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
- (2013) R. Panaccione et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab Therapy Is Associated With Reduced Risk of Hospitalization in Patients With Ulcerative Colitis
- (2013) Brian G. Feagan et al. GASTROENTEROLOGY
- Exploring the use of adalimumab for patients with moderate Crohn's disease: Subanalyses from induction and maintenance trials
- (2013) William J. Sandborn et al. Journal of Crohns & Colitis
- Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009
- (2012) Peter Laszlo Lakatos et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hospitalisations and surgery in Crohn's disease
- (2012) Charles N Bernstein et al. GUT
- Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn’s disease
- (2011) M. A. Kamm et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2011) William J. Sandborn et al. GASTROENTEROLOGY
- Hospitalization and surgical rates in patients with Crohn's disease treated with infliximab: a matched analysis
- (2011) John Paul Leombruno et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study
- (2010) A. Gustavsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn’s disease
- (2010) R. PANACCIONE et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
- (2010) Jean Frédéric Colombel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease
- (2009) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohnʼs disease†
- (2009) Daniel J. Stein et al. INFLAMMATORY BOWEL DISEASES
- Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study
- (2008) Brian G. Feagan et al. GASTROENTEROLOGY
- Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort
- (2008) F Schnitzler et al. GUT
- The Direct and Indirect Cost Burden of Crohnʼs Disease and Ulcerative Colitis
- (2008) Teresa B. Gibson et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial
- (2008) Geert D'Haens et al. LANCET
- Loss of Treatment Response to Infliximab Maintenance Therapy in Crohn's Disease: A Payor Perspective
- (2008) Eric Qiong Wu et al. VALUE IN HEALTH
- Short health scale: A valid, reliable, and responsive instrument for subjective health assessment in Crohnʼs disease
- (2007) Henrik Stjernman et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More